Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Apotex and Strides to merge Australia units

Executive Summary

Apotex and Strides Shasun have agreed in principle to merge their Australian businesses under a new entity, in a deal that will allow the combined company to become “the leading player in the Australian generic pharmaceutical market by both volume and revenue”. Strides will have a “controlling interest in the merged entity”, with the share-swap transaction subject to a final definitive agreement between the firms, as well as due diligence and regulatory approvals including from the Australian Competition and Consumer Commission (ACCC).

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

GB000684

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel